NVIDIA (NVDA) and Eli Lilly (LLY) announce co-innovation AI lab to reinvent drug discovery in the age of AI
Importance
Level 1
- The two companies will invest up to USD 1bln in talent, infrastructure and compute over five years to support the new AI co-innovation lab.
#ELI LILLY & CO#LLY.US#NVIDIA CORP#NVDA.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#SEMICONDUCTORS#PHARMACEUTICALS (GROUP)#SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT#S&P 500 INDEX#NASDAQ 100 INDEX#ELI LILLY AND CO#LLY#NVDA#US EQUITIES#AI